Literature DB >> 8399121

DNA typing for HLA-DPB1-alleles in German patients with systemic lupus erythematosus using the polymerase chain reaction and DIG-ddUTP-labelled oligonucleotide probes. Members of SLE Study Group.

Z Yao1, K Hartung, H G Deicher, G Brünnler, M P Bettinotti, E Keller, C Paul, C Gawron, S Mikschl, E Albert.   

Abstract

Genomic DNA of 178 German Caucasian patients with systemic lupus erythematosus are studied for HLA-DP locus by using PCR and DIG-ddUTP-labelled oligonucleotide probes. A significant increase of DPB1*0101 is observed in SLE patients compared with healthy controls (chi 2 = 15.27, p.c. < 0.004). DPB1*0501 and *0901 are also slightly increased (chi 2 = 5.85, P < 0.05, p.c. = NS; chi 2 = 5.64, P < 0.05, p.c. = NS). There is no significant difference in frequency of DP alleles between male and female patients. Since a linkage disequilibrium between HLA-B, DR and DP loci is found in our SLE patients, an analysis is performed assessing the relative importance of these HLA-markers to SLE. The results show that the increase of DPB1*0101 in SLE patients is associated with the HLA-B8, DR3 haplotype and it suggests a more important role for HLA-B8, DR3 or genes within this haplotype than for DPB1*0101 in the genetic predisposition for SLE.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8399121     DOI: 10.1111/j.1744-313x.1993.tb00141.x

Source DB:  PubMed          Journal:  Eur J Immunogenet        ISSN: 0960-7420


  10 in total

1.  Balancing selection and heterogeneity across the classical human leukocyte antigen loci: a meta-analytic review of 497 population studies.

Authors:  Owen D Solberg; Steven J Mack; Alex K Lancaster; Richard M Single; Yingssu Tsai; Alicia Sanchez-Mazas; Glenys Thomson
Journal:  Hum Immunol       Date:  2008-06-09       Impact factor: 2.850

Review 2.  Recent advances in the genetics of systemic lupus erythematosus.

Authors:  Donna L Thibault Flesher; Xin Sun; Timothy W Behrens; Robert R Graham; Lindsey A Criswell
Journal:  Expert Rev Clin Immunol       Date:  2010-05       Impact factor: 4.473

3.  MHC region and risk of systemic lupus erythematosus in African American women.

Authors:  Edward A Ruiz-Narvaez; Patricia A Fraser; Julie R Palmer; L Adrienne Cupples; David Reich; Ying A Wang; John D Rioux; Lynn Rosenberg
Journal:  Hum Genet       Date:  2011-06-22       Impact factor: 4.132

4.  Variants in TNFSF4, TNFAIP3, TNIP1, BLK, SLC15A4 and UBE2L3 interact to confer risk of systemic lupus erythematosus in Chinese population.

Authors:  Xian-Bo Zuo; Yu-Jun Sheng; Su-Juan Hu; Jin-Ping Gao; Yang Li; Hua-Yang Tang; Xian-Fa Tang; Hui Cheng; Xian-Yong Yin; Lei-Lei Wen; Liang-Dan Sun; Sen Yang; Yong Cui; Xue-Jun Zhang
Journal:  Rheumatol Int       Date:  2013-10-04       Impact factor: 2.631

5.  Polymorphism of the DQA1 promoter region (QAP) and DRB1, QAP, DQA1, DQB1 haplotypes in systemic lupus erythematosus. SLE Study Group members.

Authors:  Z Yao; A Kimura; K Hartung; P J Haas; A Volgger; G Brünnler; J Bönisch; E D Albert
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

6.  Immunosuppressive therapy modulates T lymphocyte gene expression in patients with systemic lupus erythematosus.

Authors:  Elayne Pereira; Márcia Cristina Tamia-Ferreira; Renato Sousa Cardoso; Stephano Spanó Mello; Elza Tiemi Sakamoto-Hojo; Geraldo A S Passos; Eduardo Antonio Donadi
Journal:  Immunology       Date:  2004-09       Impact factor: 7.397

7.  HLA-DP does not contribute towards susceptibility to systemic lupus erythematosus.

Authors:  E J Davies; C J Hutchings; M C Hillarby; R P Donn; R G Cooper; E M Hay; R M Bernstein; P J Holt; D M Grennan; W E Ollier
Journal:  Ann Rheum Dis       Date:  1994-03       Impact factor: 19.103

8.  No direct correlation between HLA-DPB1 and antibodies against recombinant Ro (SS-A)/La (SS-B) proteins in systemic lupus erythematosus. SLE Study Group.

Authors:  Z Yao; K Hartung; H Ehrfeld; H P Seelig; H G Deicher; G Brünnler; E Keller; E Albert
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

9.  HLA class II genes and antibodies against recombinant U1-nRNP proteins in patients with systemic lupus erythematosus. SLE Study Group.

Authors:  Z Yao; H P Seelig; H Ehrfeld; M Renz; K Hartung; H Deicher; E Keller; C Nevinny-Stickel; E D Albert
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

Review 10.  Role of MHC-linked susceptibility genes in the pathogenesis of human and murine lupus.

Authors:  Manfred Relle; Andreas Schwarting
Journal:  Clin Dev Immunol       Date:  2012-06-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.